Bangladesh’s medicine exports recorded 4.49 percent growth in the 2019-20 fiscal year amid coronavirus while export of other products witnessed downturns. Industry people said Bangladeshi drugs for Covid-19 treatment have created a substantial demand in the international market, and the pharma sector will see a handsome growth at least in the next six months. The pharmaceuticals had been posting gradual export growth in pre-pandemic years too. Bangladesh in the last fiscal year earned $135.79 million by selling locally manufactured drugs in the international market. According to the Export Promotion Bureau (EPB), earnings in 2018-19 fiscal were $130 million, and $103.46 million in FY2017-18. Beacon Pharmaceuticals Director (global business development) Monjurul Alam said many counties are aware of the quality of Bangladeshi drugs as the thriving industry has 10-15 major market players. “The demand for drugs like Remdesivir or Favipiravir is good,” he added. “Beacon Pharmaceuticals has a greater export growth than the local market. The International export market for local drugs is expanding due to the major market players,” Monjurul further said. “They have also expanded the capacity and modernised the plants. We are getting the outputs now as Bangladeshi drugs have earned a distinct place at international level,” added the Beacon pharma official. According to the Bangladesh Association of Pharmaceuticals Industries (BAPI), Bangladesh exports medicine to 150 countries. Local companies meet almost 98 percent of domestic demand worth around $2 billion. Square Pharmaceuticals is the major player dominating Bangladesh’s pharmaceutical industry with 18.8 percent share, followed by Incepta at 10.2 percent, Beximco 8.5 percent, Opsonin 5.6 percent, Renata 5.1 percent and Eskayef 4.5 percent. Industry insiders said the local pharma sector saw a major progress in the last 20 years. International standard factories were set up in the country during this time as the sector got large investments. With almost all generic drugs manufactured locally, Bangladesh has emerged as one of the key competing countries in the world.
Recent Article
বিদেশি বিনিয়োগ প্রস্তাব কমেছে ৮৬ শতাংশ
করোনার ধাক্কায় দেশে বিদেশি বিনিয়োগ নিবন্ধন অনেক কমে গেছে। বাংলাদেশ বিনিয়োগ উন্নয়ন কর্তৃপক্ষের (বিডা) কাছে চলতি বছরের জানুয়ারি থেকে জুন পর্যন্ত ছয়...
হঠাত্ নগদ ডলারের সংকট, কমে যাচ্ছে টাকার মান
বাজারে চাহিদা ও জোগানের ব্যবধানে ডলারের সংকট তীব্র আকার ধারণ করেছে। এতে বাড়ছে ডলারের দাম। আমদানিকারকদের গুনতে হচ্ছে বাড়তি অর্থ। আর এর...
Bangladesh now a model for effective disaster management: PM
Prime Minister Sheikh Hasina today said Bangladesh is now a model country in the world in disaster management as it has been...
Automotive industry could attract Japanese investment: DCCI president
The automotive industry in Bangladesh could be an emerging investment destination for Japanese entrepreneurs, said Dhaka Chamber of Commerce and Industry president...
Success of businesses drives growth: ICCB
The success of businesses can drive the growth of a country and help achieve an overall sustainable development and create employment opportunities,...